InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,792.04
(
0.71%
)
US TECH 100
19,695.60
(
0.63%
)
Dow Jones
42,512.00
(
1.03%
)
Brent Oil
76.52
(
-1.07%
)
Bitcoin
60,939.68
(
-1.92%
)
Post# of 253324
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 839
Posts 120552
Boards Moderated 14
Alias Born 09/05/2002

DewDiligence

Member Level

Re: genisi post# 67271

Friday, 10/10/2008 7:05:29 PM

Friday, October 10, 2008 7:05:29 PM

Post# of 253324
Good article, but readers should examine #msg-30789679 for the counterpoint argument.

Also, there are a couple of factual inaccuracies in the article: i) I don’t think it’s correct to say that King has “removed” bovine factor V from Thrombin-JMI; and ii) GTCB is no longer planning to develop recombinant albumin, although the technology to make it in transgenic cows has been shown to work.

Thanks for posting the article. Regards, Dew

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up